EBITDA Margin ratio Analysis of Arcutis Biotherapeutics Inc - Deep Dive
Latest FY EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-484.34
Period Ending - Dec-22
Very Poor EBITDA Margin
-7999.78
Growth
93.95 %
Trailing Twelve Months EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-181.47
Most recent Quarter EBITDA Margin
Period Ending - Mar-24
Very Poor EBITDA Margin
-63.07
EBITDA Margin Analysis of Arcutis Biotherapeutics Inc
Ebitda Margin Ratio of Arcutis Biotherapeutics Inc with value of -181.47 means that its operating expenses are Higher in relation to total revenue in trailing twelve months. |
Ebitda Margin Ratio of Arcutis Biotherapeutics Inc with value of -63.07 means that its operating expenses are Higher in relation to total revenue in latest Quarter ending on Mar-24. |
EBITDA Margin Ratio of ARQT rose handsomely by 93.95 % this year. |
EBITDA Margin Ratio with value of 0 was highest in Year Dec-21 in last Five Years. |
EBITDA Margin Ratio with value of -7999.78 was lowest in Year Dec-22 in last Five Years. |
Latest EBITDA Margin Ratio with value of -484.34 is Greater than Average EBITDA Margin of -1696.83 in last five years. |
Ebitda Margin of Arcutis Biotherapeutics Inc is negative because of negative EBITDA in last Financial Year , last Quarter and also in last twelve Months |
Other EBITDA Margin Related Info of ARQT that may interest you.
Arcutis Biotherapeutics Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
ARQT | 8.36 | 8.66 | 3.46 % | Biotechnology |
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..EBITDA Margin Related Ratios
NetProfitMargin | ReturnOnEquity |
Tsr Profitability Index
Poor Profitability Stock |
FY - Historical EBITDA Margin of Arcutis Biotherapeutics Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
EBITDA Margin | -484.34 | -7999.78 | 0 | 0 | 0 | 0 | 0 |
Change | 93.95 % |
FY Chart of EBITDA Margin of Arcutis Biotherapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)